VALION BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.55
-10.83%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-78.1%
3 months
-93.0%
6 months
-97.6%
1 year
-99.1%
Year to date
-98.5%
52-week range
$0.55 – $66.50
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$500K
P/E
0
P/B
0.1
P/S
-3.2
Revenue
-$156K
Net income
-$18.75M
Diluted EPS
-193.2
Gross margin
66.70%
Net margin
12019.20%
Return on equity
-199.00%
Total debt
$17.41M
Cash
$2.48M
Free cash flow
-$14.67M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$7.1M | — | — | -$5.34M |
| Mar 31, 2026 | $0 | -$6.2M | — | — | -$5.02M |
| Dec 31, 2025 | -$302K | -$2.85M | -13.60% | 943.40% | -$2.31M |
| Sep 30, 2025 | $146K | -$2.6M | -99.30% | -1778.10% | -$2.01M |
| Jun 30, 2025 | $86K | -$1.93M | 62.80% | -2245.30% | -$1.83M |
| Mar 31, 2025 | $70K | -$1.5M | 71.40% | -2145.70% | -$889K |
| Dec 31, 2024 | $180K | -$1.48M | -132.80% | -820.60% | -$1.37M |
| Sep 30, 2024 | $126K | -$1.43M | 34.90% | -1135.70% | -$1.41M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent VBIO news
All market newsNo ticker-linked stories are in the current archive.